Kashmolah Ghazi's Form 4 filing
Lucira Health, Inc. (LHDX) · filed Aug 19, 2022
- Accession no.
- 0001209191-22-046962
- Filed
- Aug 19, 2022
- Trade date
- Aug 17-18, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $61.9K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001209191-22-047309 (Aug 24, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kashmolah GhaziCIK 0001877741 | Officer (Ex VP & Chief Quality Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Common Stock | SSaleDisposed | −19,074 | $2.83 | −$53,979.42 | 180,757 | Direct | |
| Aug 18, 2022 | Common Stock | SSaleDisposed | −3,500 | $2.25 | −$7,875 | 177,257 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.